Patent Assignment
Reel/Frame 046585/0156
Assignment of Assignor's Interest
Recorded: 2018-08-08
Pages: 3
Assignor
WKD HOLDING OY
Executed: 2013-08-19
Assignee
TRIZELL LTD.
38 OAKLEY ROAD, SANDERUM HOUSE, CHINNOR, OX39 4TW, UNITED KINGDOM
Covered Properties
(2)
Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
Application:
13/969,763 →
Publication:
US 2014/0057851
Antiangiogenic Gene Therapy with Soluble VEGF-receptors -1, -2 and -3 Together with Paclitaxel Prolongs Survival of Mice with Human Ovarian Carcinoma
Application:
61/692,828 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 8, 2018
From: YLA-HERTTUALA, SEPPO; PARKER, NIGEL; SOPO, MINNA; SALLINEN, HANNA
To: WKD HOLDING OY
Reel/Frame 046748/0608 →
Security Interest
Nov 19, 2020
From: TRIZELL LTD.
To: PHARMACEUTICAL PATENT ATTORNEYS, LLC
Reel/Frame 054775/0546 →
Release of Security Interest
Jan 31, 2022
From: PHARMACEUTICAL PATENT ATTORNEYS, LLC
To: TRIZELL LTD., F/K/A FINVECTOR LTD. F/K/A ARK THERAPEUTICS LTD.
Reel/Frame 058826/0044 →